Cite
MLA Citation
M. Dickinson et al.. “S212: PHASE I STUDY OF YTB323, A CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY MANUFACTURED USING T-CHARGE™, IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.” HemaSphere, vol. 6, n.d., pp. 113–114. http://access.bl.uk/ark:/81055/vdc_100158013526.0x000011